\-\ Texto\\:\\ \ \(0\)\
\-\ treatment\\ presently\\ consists\\ of\\ surgery\\ \\(either\\ palliative\\ or\\ gastrectomy\\)\\;\\ radiation\\ \\(not\\ normally\\ used\\ due\\ to\\ proximity\\ of\\ other\\ vital\\ organs\\ \\)\\;\\ or\\ chemotherapy\\ using\\ a\\ triple\\ regimen\\ of\\ 5\\-fu\\,\\ mitomycin\\ c\\ and\\ doxorubicin\\ with\\ up\\ to\\ a\\ 30\\%\\ response\\ in\\ early\\ diagnosed\\ gastric\\ ca\\.\ \(0\)\
\-\ an\\ abdominal\\ ct\\ with\\ contrast\\ was\\ obtained\\.\\ \\ a\\.\\ although\\ this\\ is\\ an\\ abdominal\\ ct\\ with\\ contrast\\,\\ note\\ the\\ sequestration\\ of\\ contrast\\ material\\ in\\ the\\ stomach\\ secondary\\ to\\ complete\\ gastric\\ outlet\\ obstruction\\.\\ there\\ is\\ a\\ 2\\ cm\\ mass\\ posterior\\ to\\ the\\ stomach\\ in\\ the\\ vicinity\\ of\\ the\\ antrum\\.\\ there\\ is\\ a\\ cleavage\\ plane\\ between\\ the\\ mass\\ and\\ the\\ head\\ of\\ the\\ pancreas\\ which\\ suggests\\ a\\ gastric\\ etiology\\.\\ there\\ is\\ a\\ large\\ infarct\\ in\\ the\\ right\\ lobe\\ of\\ the\\ liver\\,\\ most\\ likely\\ secondary\\ to\\ right\\ portal\\ vein\\ thrombosis\\.\\ \\ b\\.\\ 2cm\\ gastric\\ mass\\ can\\ be\\ seen\\.\\ omental\\ caking\\ is\\ indicative\\ of\\ carcinomatosis\\ is\\ seen\\ anterior\\ to\\ the\\ liver\\.\\ significant\\ ascites\\ is\\ noted\\ throughout\\ the\\ abdomen\\.\\ there\\ are\\ multiple\\ hypodensities\\ in\\ both\\ kidneys\\ which\\ appear\\ consistent\\ with\\ a\\ cystic\\ etiology\\.\\ adenopathy\\ is\\ present\\ in\\ the\\ periaortic\\ and\\ parapancreatic\\ regions\\.\\ \\ c\\.\\ more\\ evidence\\ of\\ omental\\ caking\\,\\ ascites\\,\\ renal\\ cysts\\ and\\ marked\\ adenopathy\\.\ \(0\)\
\-\ adenocarcinoma\\ of\\ gastric\\ antrum\ \(0\)\
\-\ 54yo\\ caucasian\\ male\\ with\\ 3\\ month\\ history\\ of\\ progressive\\ early\\ satiety\\,\\ post\\ prandial\\ vomiting\\ and\\ anorexia\\.\\ patient\\ reported\\ weight\\ loss\\ in\\ excess\\ of\\ 15\\ pounds\\ during\\ previous\\ 1\\ month\\.\\ patient\\ has\\ an\\ 80\\ pack\\ year\\ history\\ of\\ smoking\\ and\\ 25\\ year\\ history\\ of\\ heavy\\ alcohol\\ ingestion\\.\ \(0\)\
\-\ stomach\\ cancer\\ is\\ the\\ most\\ common\\ internal\\ malignancy\\ worldwide\\.\\ adenocarcinoma\\ is\\ the\\ responsible\\ etiology\\ for\\ over\\ 90\\%\\ of\\ gastric\\ neoplasms\\.\\ over\\ half\\ of\\ gastric\\ adenocarcinomas\\ are\\ located\\ in\\ the\\ antrum\\,\\ the\\ rest\\ are\\ distributed\\ in\\ the\\ body\\,\\ cardia\\,\\ and\\ fundus\\ in\\ descending\\ order\\.\\ patients\\ typically\\ present\\ with\\ weight\\ loss\\,\\ anorexia\\,\\ dyspepsia\\,\\ early\\ satiety\\,\\ anemia\\ \\(iron\\ deficiency\\)\\,\\ hematemesis\\.\\ a\\ left\\ supraclavicular\\ \\(virchow\\'s\\ node\\)\\ lymph\\ node\\ may\\ be\\ palpable\\ late\\ in\\ the\\ disease\\.\\ lymph\\ node\\ metastases\\ are\\ present\\ in\\ greater\\ than\\ 50\\%\\ of\\ patients\\ at\\ time\\ of\\ diagnosis\\.\\ although\\ the\\ exact\\ etiology\\ remains\\ unknown\\,\\ risk\\ factors\\ for\\ this\\ disease\\ appear\\ to\\ be\\:\\ male\\ sex\\,\\ race\\ \\(japan\\ has\\ 5\\-10\\ times\\ the\\ incidence\\ as\\ the\\ usa\\ believed\\ due\\ to\\ polycyclic\\ hydrocarbon\\ ingestion\\ in\\ smoked\\ fish\\)\\,\\ chile\\ also\\ has\\ a\\ much\\ higher\\ incidence\\,\\ age\\ \\(50\\ plus\\)\\,\\ precancerous\\ lesions\\ \\(such\\ as\\ pernicious\\ anemia\\ \\(atrophic\\ gastritis\\ type\\ a\\)\\,\\ adenomatous\\ polyp\\,\\ chronic\\ h\\.\\ pylori\\ gastritis\\)\\,\\ status\\ post\\ subtotal\\ gastrectomy\\.\\ dietary\\ risk\\ factors\\ may\\ be\\ the\\ most\\ significant\\.\\ ingestion\\ of\\ increased\\ salt\\ and\\ smoked\\ foods\\,\\ vitamin\\ c\\ deficiency\\,\\ poor\\ carbohydrate\\ intake\\,\\ and\\ increased\\ nitrate\\ consumption\\ are\\ apparent\\ risk\\ factors\\ for\\ this\\ cancer\\.\\ there\\ has\\ been\\ a\\ definitive\\ correlation\\ between\\ well\\ water\\ nitrate\\ content\\ and\\ gastric\\ ca\ \(0\)\
\-\ \\ \\ \\ \\ \\ the\\ prognosis\\ for\\ gastric\\ ca\\ is\\ remains\\ poor\\ in\\ the\\ long\\ term\\.\\ early\\ diagnosis\\ where\\ the\\ cancer\\ is\\ restricted\\ to\\ the\\ gastric\\ mucosa\\ and\\ submucosa\\ has\\ a\\ 85\\%\\ five\\ year\\ survival\\.\\ tumors\\ that\\ have\\ invaded\\ the\\ muscle\\ wall\\,\\ but\\ not\\ the\\ lymph\\ nodes\\ have\\ a\\ 30\\%\\ five\\ year\\ survival\\,\\ and\\ tumors\\ that\\ have\\ extended\\ through\\ the\\ full\\ thickness\\ of\\ the\\ wall\\ and\\ involves\\ lymph\\ nodes\\ has\\ a\\ very\\ poor\\ 5\\%\\ five\\ year\\ survival\\ rate\\.\\ most\\ cancers\\ are\\ diagnosed\\ in\\ late\\ stage\\ which\\ is\\ when\\ symptoms\\ present\\.\\ gastric\\ ca\\ is\\ spread\\ by\\ several\\ means\\,\\ including\\:\\ 1\\)\\ direct\\ extension\\ to\\ the\\ liver\\,\\ greater\\ omentum\\,\\ pancreas\\,\\ spleen\\;\\ 2\\)\\ lymphatic\\:\\ local\\ nodes\\,\\ regional\\ nodes\\,\\ distant\\ nodes\\;\\ 3\\)\\ hematogenous\\:\\ hepatic\\,\\ pulmonary\\,\\ bone\\,\\ cns\\.\ \(0\)\
\-\ \\ \\ \\ \\ \\ in\\ the\\ case\\ of\\ this\\ patient\\ who\\ presented\\ very\\ late\\ in\\ his\\ illness\\ he\\ died\\ less\\ than\\ 5\\ weeks\\ after\\ his\\ initial\\ presentation\\.\\ this\\ patient\\ demonstrated\\ a\\ classic\\ presentation\\ for\\ this\\ illness\\-\\ post\\ prandial\\ vomiting\\ \\(approx\\ 30\\ mins\\ after\\ meal\\)\\,\\ significant\\ weight\\ loss\\,\\ liquid\\ diet\\ for\\ 2\\ months\\ \\(unable\\ to\\ pass\\ solids\\ thru\\ antrum\\)\\ which\\ ultimately\\ progressed\\ to\\ an\\ inability\\ to\\ tolerate\\ liquids\\ for\\ 2\\ weeks\\ prior\\ to\\ admission\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ gastric\\:\\ 0\\.057378917557686086\ \(0\)\
\-\ antrum\\:\\ 0\\.02958645378308384\ \(0\)\
\-\ nodes\\:\\ 0\\.026364012065336322\ \(0\)\
\-\ prandial\\:\\ 0\\.024086115912476773\ \(0\)\
\-\ ca\\:\\ 0\\.021744461841612134\ \(0\)\
\-\ ingestion\\:\\ 0\\.021330329964435547\ \(0\)\
\-\ caking\\:\\ 0\\.02029842640122024\ \(0\)\
\-\ nitrate\\:\\ 0\\.02029842640122024\ \(0\)\
\-\ etiology\\:\\ 0\\.01976514422240805\ \(0\)\
\-\ gastrectomy\\:\\ 0\\.019688744567028408\ \(0\)\
\-\ lymph\\:\\ 0\\.018849958518823207\ \(0\)\
\-\ survival\\:\\ 0\\.01877627835807065\ \(0\)\
\-\ late\\:\\ 0\\.01822160070286671\ \(0\)\
\-\ smoked\\:\\ 0\\.017794899811400144\ \(0\)\
\-\ five\\:\\ 0\\.017465743985106384\ \(0\)\
\-\ gastritis\\:\\ 0\\.017078057558756726\ \(0\)\
\-\ early\\:\\ 0\\.017077371418811136\ \(0\)\
\-\ satiety\\:\\ 0\\.016875576760522513\ \(0\)\
\-\ \\%\\:\\ 0\\.01633869699463941\ \(0\)\
\-\ anorexia\\:\\ 0\\.01618892531713206\ \(0\)\
\-\ node\\:\\ 0\\.01602558871118061\ \(0\)\
\-\ poor\\:\\ 0\\.015761086575370894\ \(0\)\
\-\ factors\\:\\ 0\\.015732724104696408\ \(0\)\
\-\ omental\\:\\ 0\\.015640644728437656\ \(0\)\
\-\ stomach\\:\\ 0\\.015485925498167498\ \(0\)\
\-\ \\,\\:\\ 0\\.014053254767290876\ \(0\)\
\-\ 30\\:\\ 0\\.013467579247766702\ \(0\)\
\-\ ascites\\:\\ 0\\.013397528465951781\ \(0\)\
\-\ has\\:\\ 0\\.01315327844667441\ \(0\)\
\-\ risk\\:\\ 0\\.01268527314491429\ \(0\)\
\-\ \\)\\:\\ 0\\.012672117482886564\ \(0\)\
\-\ deficiency\\:\\ 0\\.012597884711955007\ \(0\)\
\-\ weight\\:\\ 0\\.012553056496478957\ \(0\)\
\-\ remains\\:\\ 0\\.012147733801911139\ \(0\)\
\-\ liver\\:\\ 0\\.012074678323084934\ \(0\)\
\-\ parapancreatic\\:\\ 0\\.012043057956238386\ \(0\)\
\-\ polycyclic\\:\\ 0\\.012043057956238386\ \(0\)\
\-\ hydrocarbon\\:\\ 0\\.012043057956238386\ \(0\)\
\-\ chile\\:\\ 0\\.012043057956238386\ \(0\)\
\-\ precancerous\\:\\ 0\\.012043057956238386\ \(0\)\
\-\ illness\\-\\:\\ 0\\.012043057956238386\ \(0\)\
\-\ pancreas\\:\\ 0\\.011947724501301042\ \(0\)\
\-\ anemia\\:\\ 0\\.011615219214477219\ \(0\)\
\-\ cancer\\:\\ 0\\.011512972394937563\ \(0\)\
\-\ c\\:\\ 0\\.011098164570656103\ \(0\)\
\-\ 5\\-fu\\:\\ 0\\.011096135578424253\ \(0\)\
\-\ 54yo\\:\\ 0\\.011096135578424253\ \(0\)\
\-\ carbohydrate\\:\\ 0\\.011096135578424253\ \(0\)\
\-\ mins\\:\\ 0\\.011096135578424253\ \(0\)\
\-\ \\;\\:\\ 0\\.011067875346735484\ \(0\)\
\-\ post\\:\\ 0\\.011028012430624155\ \(0\)\
\-\ most\\:\\ 0\\.010780519900153421\ \(0\)\
\-\ is\\:\\ 0\\.010754195215008413\ \(0\)\
\-\ incidence\\:\\ 0\\.01070403995632674\ \(0\)\
\-\ present\\:\\ 0\\.01054649592312394\ \(0\)\
\-\ mitomycin\\:\\ 0\\.010542221496309274\ \(0\)\
\-\ dyspepsia\\:\\ 0\\.010542221496309274\ \(0\)\
\-\ pernicious\\:\\ 0\\.010542221496309274\ \(0\)\
\-\ adenopathy\\:\\ 0\\.010395855546093558\ \(0\)\
\-\ loss\\:\\ 0\\.010165836772411637\ \(0\)\
\-\ vicinity\\:\\ 0\\.01014921320061012\ \(0\)\
\-\ cleavage\\:\\ 0\\.01014921320061012\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.010086214329407758\ \(0\)\
\-\ 2\\:\\ 0\\.010055215827926482\ \(0\)\
\-\ \\(\\:\\ 0\\.009868329593495363\ \(0\)\
\-\ adenocarcinomas\\:\\ 0\\.009844372283514204\ \(0\)\
\-\ fish\\:\\ 0\\.009844372283514204\ \(0\)\
\-\ thru\\:\\ 0\\.009844372283514204\ \(0\)\
\-\ in\\:\\ 0\\.009786547694514118\ \(0\)\
\-\ appear\\:\\ 0\\.00955573341563465\ \(0\)\
\-\ are\\:\\ 0\\.009548146496144277\ \(0\)\
\-\ significant\\:\\ 0\\.009417406356779604\ \(0\)\
\-\ virchow\\:\\ 0\\.00938471075807539\ \(0\)\
\-\ japan\\:\\ 0\\.00938471075807539\ \(0\)\
\-\ submucosa\\:\\ 0\\.00938471075807539\ \(0\)\
\-\ invaded\\:\\ 0\\.00938471075807539\ \(0\)\
\-\ periaortic\\:\\ 0\\.009202290822795986\ \(0\)\
\-\ worldwide\\:\\ 0\\.009202290822795986\ \(0\)\
\-\ cardia\\:\\ 0\\.009202290822795986\ \(0\)\
\-\ salt\\:\\ 0\\.009202290822795986\ \(0\)\
\-\ presently\\:\\ 0\\.009041385036380162\ \(0\)\
\-\ consumption\\:\\ 0\\.009041385036380162\ \(0\)\
\-\ omentum\\:\\ 0\\.009041385036380162\ \(0\)\
\-\ vomiting\\:\\ 0\\.008914095188647215\ \(0\)\
\-\ hematemesis\\:\\ 0\\.008897449905700072\ \(0\)\
\-\ race\\:\\ 0\\.008897449905700072\ \(0\)\
\-\ 50\\:\\ 0\\.008882508242196187\ \(0\)\
\-\ greater\\:\\ 0\\.008769716824236341\ \(0\)\
\-\ tumors\\:\\ 0\\.008769716824236341\ \(0\)\
\-\ hypodensities\\:\\ 0\\.008767244742032962\ \(0\)\
\-\ which\\:\\ 0\\.008716637088757096\ \(0\)\
\-\ there\\:\\ 0\\.008686581669842819\ \(0\)\
\-\ diagnosed\\:\\ 0\\.008585232668838812\ \(0\)\
\-\ pylori\\:\\ 0\\.008539028779378363\ \(0\)\
\-\ subtotal\\:\\ 0\\.008539028779378363\ \(0\)\
\-\ foods\\:\\ 0\\.008539028779378363\ \(0\)\
\-\ very\\:\\ 0\\.008474824094145161\ \(0\)\
\-\ doxorubicin\\:\\ 0\\.008437788380261256\ \(0\)\
\-\ meal\\:\\ 0\\.008437788380261256\ \(0\)\
\-\ liquids\\:\\ 0\\.008437788380261256\ \(0\)\
\-\ distributed\\:\\ 0\\.008255368444981854\ \(0\)\
\-\ plus\\:\\ 0\\.008255368444981854\ \(0\)\
\-\ sex\\:\\ 0\\.008172547923374702\ \(0\)\
\-\ liquid\\:\\ 0\\.008172547923374702\ \(0\)\
\-\ to\\:\\ 0\\.00816796928716094\ \(0\)\
\-\ a\\:\\ 0\\.008127045119233633\ \(0\)\
\-\ usa\\:\\ 0\\.00809446265856603\ \(0\)\
\-\ solids\\:\\ 0\\.00809446265856603\ \(0\)\
\-\ presentation\\:\\ 0\\.008042078236314433\ \(0\)\
\-\ 5\\-10\\:\\ 0\\.008020600334426309\ \(0\)\
\-\ tolerate\\:\\ 0\\.008020600334426309\ \(0\)\
\-\ proximity\\:\\ 0\\.007950527527885939\ \(0\)\
\-\ although\\:\\ 0\\.007885052679171048\ \(0\)\
\-\ triple\\:\\ 0\\.007883874298146278\ \(0\)\
\-\ atrophic\\:\\ 0\\.007883874298146278\ \(0\)\
\-\ content\\:\\ 0\\.007883874298146278\ \(0\)\
\-\ this\\:\\ 0\\.007878173879624042\ \(0\)\
\-\ contrast\\:\\ 0\\.007839244618065186\ \(0\)\
\-\ excess\\:\\ 0\\.007820322364218828\ \(0\)\
\-\ adenomatous\\:\\ 0\\.007820322364218828\ \(0\)\
\-\ dietary\\:\\ 0\\.007820322364218828\ \(0\)\
\-\ lymphatic\\:\\ 0\\.007759595912619328\ \(0\)\
\-\ heavy\\:\\ 0\\.007645686610790023\ \(0\)\
\-\ responsible\\:\\ 0\\.007592106401564229\ \(0\)\
\-\ approx\\:\\ 0\\.007592106401564229\ \(0\)\
\-\ have\\:\\ 0\\.007583762616250376\ \(0\)\
\-\ 2cm\\:\\ 0\\.007540548576451051\ \(0\)\
\-\ hematogenous\\:\\ 0\\.007540548576451051\ \(0\)\
\-\ outlet\\:\\ 0\\.007490866002447123\ \(0\)\
\-\ h\\.\\:\\ 0\\.007490866002447123\ \(0\)\
\-\ between\\:\\ 0\\.007400261027935093\ \(0\)\
\-\ pack\\:\\ 0\\.00739661344577096\ \(0\)\
\-\ means\\:\\ 0\\.00739661344577096\ \(0\)\
\-\ regional\\:\\ 0\\.00739661344577096\ \(0\)\
\-\ iron\\:\\ 0\\.007351818605848842\ \(0\)\
\-\ regimen\\:\\ 0\\.007308446067167721\ \(0\)\
\-\ pounds\\:\\ 0\\.007266408282103849\ \(0\)\
\-\ exact\\:\\ 0\\.007225625545560569\ \(0\)\
\-\ be\\:\\ 0\\.00720085641171546\ \(0\)\
\-\ supraclavicular\\:\\ 0\\.007186025085351208\ \(0\)\
\-\ intake\\:\\ 0\\.007186025085351208\ \(0\)\
\-\ carcinomatosis\\:\\ 0\\.0071475402807518965\ \(0\)\
\-\ diet\\:\\ 0\\.0071475402807518965\ \(0\)\
\-\ palliative\\:\\ 0\\.007110109988145183\ \(0\)\
\-\ cancers\\:\\ 0\\.007038192319449251\ \(0\)\
\-\ month\\:\\ 0\\.007004411313662868\ \(0\)\
\-\ believed\\:\\ 0\\.007003605150071805\ \(0\)\
\-\ for\\:\\ 0\\.006972345683741811\ \(0\)\
\-\ sequestration\\:\\ 0\\.006904806432066851\ \(0\)\
\-\ vitamin\\:\\ 0\\.006873399986404695\ \(0\)\
\-\ died\\:\\ 0\\.006842699363655982\ \(0\)\
\-\ 5\\:\\ 0\\.006831039405585146\ \(0\)\
\-\ distant\\:\\ 0\\.006812673534805196\ \(0\)\
\-\ ultimately\\:\\ 0\\.006812673534805196\ \(0\)\
\-\ wall\\:\\ 0\\.006762729836717885\ \(0\)\
\-\ c\\.\\:\\ 0\\.006754531985052743\ \(0\)\
\-\ fundus\\:\\ 0\\.006754531985052743\ \(0\)\
\-\ extended\\:\\ 0\\.006754531985052743\ \(0\)\
\-\ progressed\\:\\ 0\\.006754531985052743\ \(0\)\
\-\ his\\:\\ 0\\.006729204993570852\ \(0\)\
\-\ pass\\:\\ 0\\.0067263635599123925\ \(0\)\
\-\ organs\\:\\ 0\\.006698764232975891\ \(0\)\
\-\ inability\\:\\ 0\\.006698764232975891\ \(0\)\
\-\ indicative\\:\\ 0\\.00667171146344559\ \(0\)\
\-\ polyp\\:\\ 0\\.006645184023750096\ \(0\)\
\-\ weeks\\:\\ 0\\.006626441958746307\ \(0\)\
\-\ water\\:\\ 0\\.006619161899473192\ \(0\)\
\-\ a\\.\\:\\ 0\\.00654394362463299\ \(0\)\
\-\ year\\:\\ 0\\.006530773697219362\ \(0\)\
\-\ secondary\\:\\ 0\\.006527404280078709\ \(0\)\
\-\ plane\\:\\ 0\\.0065197638744971965\ \(0\)\
\-\ 85\\:\\ 0\\.0065197638744971965\ \(0\)\
\-\ illness\\:\\ 0\\.006496004663142185\ \(0\)\
\-\ an\\:\\ 0\\.006457185050736228\ \(0\)\
\-\ correlation\\:\\ 0\\.0064271100543622775\ \(0\)\
\-\ consists\\:\\ 0\\.0064048962280347085\ \(0\)\
\-\ spleen\\:\\ 0\\.006278703167746437\ \(0\)\
\-\ the\\:\\ 0\\.006232549720245425\ \(0\)\
\-\ due\\:\\ 0\\.006230265445226338\ \(0\)\
\-\ \\:\\:\\ 0\\.006176365114703088\ \(0\)\
\-\ half\\:\\ 0\\.006163187610331049\ \(0\)\
\-\ mucosa\\:\\ 0\\.006163187610331049\ \(0\)\
\-\ portal\\:\\ 0\\.006144850150860913\ \(0\)\
\-\ than\\:\\ 0\\.006117619822181076\ \(0\)\
\-\ patients\\:\\ 0\\.006042553550180399\ \(0\)\
\-\ thickness\\:\\ 0\\.006022949694948422\ \(0\)\
\-\ cns\\:\\ 0\\.005973862250650521\ \(0\)\
\-\ over\\:\\ 0\\.005944378661584597\ \(0\)\
\-\ neoplasms\\:\\ 0\\.005942090581027206\ \(0\)\
\-\ smoking\\:\\ 0\\.005895776985841848\ \(0\)\
\-\ alcohol\\:\\ 0\\.005880681581215367\ \(0\)\
\-\ response\\:\\ 0\\.00585098214591973\ \(0\)\
\-\ order\\:\\ 0\\.00585098214591973\ \(0\)\
\-\ suggests\\:\\ 0\\.00583637109521379\ \(0\)\
\-\ abdominal\\:\\ 0\\.005835844912901954\ \(0\)\
\-\ definitive\\:\\ 0\\.005765571822174739\ \(0\)\
\-\ normally\\:\\ 0\\.005751841855161757\ \(0\)\
\-\ higher\\:\\ 0\\.005724789085631457\ \(0\)\
\-\ increased\\:\\ 0\\.00571170705409742\ \(0\)\
\-\ descending\\:\\ 0\\.005698261645935964\ \(0\)\
\-\ times\\:\\ 0\\.005659412007519934\ \(0\)\
\-\ spread\\:\\ 0\\.005646703820822785\ \(0\)\
\-\ vital\\:\\ 0\\.005584877876030269\ \(0\)\
\-\ caucasian\\:\\ 0\\.005572841496683064\ \(0\)\
\-\ 1\\:\\ 0\\.005555536524480074\ \(0\)\
\-\ prognosis\\:\\ 0\\.005537355859520139\ \(0\)\
\-\ direct\\:\\ 0\\.005514200725211706\ \(0\)\
\-\ b\\:\\ 0\\.005502768690142695\ \(0\)\
\-\ 90\\:\\ 0\\.005502768690142695\ \(0\)\
\-\ 80\\:\\ 0\\.005491431527827537\ \(0\)\
\-\ 3\\:\\ 0\\.005467146247832075\ \(0\)\
\-\ involves\\:\\ 0\\.005425316034846868\ \(0\)\
\-\ much\\:\\ 0\\.005403969972137741\ \(0\)\
\-\ unable\\:\\ 0\\.0053934207288400485\ \(0\)\
\-\ rest\\:\\ 0\\.005382952323449927\ \(0\)\
\-\ kidneys\\:\\ 0\\.005372563526475584\ \(0\)\
\-\ restricted\\:\\ 0\\.005372563526475584\ \(0\)\
\-\ local\\:\\ 0\\.005362253136263312\ \(0\)\
\-\ diagnosis\\:\\ 0\\.005361255002132295\ \(0\)\
\-\ regions\\:\\ 0\\.0053418629037268696\ \(0\)\
\-\ term\\:\\ 0\\.0053418629037268696\ \(0\)\
\-\ material\\:\\ 0\\.005216265232516917\ \(0\)\
\-\ infarct\\:\\ 0\\.00517983320098391\ \(0\)\
\-\ apparent\\:\\ 0\\.005161975166055832\ \(0\)\
\-\ admission\\:\\ 0\\.005144347563820985\ \(0\)\
\-\ may\\:\\ 0\\.005121115762016732\ \(0\)\
\-\ either\\:\\ 0\\.0050843828185242294\ \(0\)\
\-\ using\\:\\ 0\\.0050677226093796685\ \(0\)\
\-\ full\\:\\ 0\\.005043107164703879\ \(0\)\
\-\ thrombosis\\:\\ 0\\.005010961676438586\ \(0\)\
\-\ metastases\\:\\ 0\\.0049873394126270275\ \(0\)\
\-\ stage\\:\\ 0\\.004979555230776429\ \(0\)\
\-\ hepatic\\:\\ 0\\.004874992283887995\ \(0\)\
\-\ mass\\:\\ 0\\.004870741831752314\ \(0\)\
\-\ history\\:\\ 0\\.0048369448266683745\ \(0\)\
\-\ after\\:\\ 0\\.004830604378713668\ \(0\)\
\-\ located\\:\\ 0\\.004804919477347625\ \(0\)\
\-\ where\\:\\ 0\\.004764538599968466\ \(0\)\
\-\ 25\\:\\ 0\\.004718888330952286\ \(0\)\
\-\ patient\\:\\ 0\\.00468083022358682\ \(0\)\
\-\ 15\\:\\ 0\\.004656211273915819\ \(0\)\
\-\ progressive\\:\\ 0\\.004613987862081015\ \(0\)\
\-\ seen\\:\\ 0\\.004613736653190411\ \(0\)\
\-\ cysts\\:\\ 0\\.004573030441026457\ \(0\)\
\-\ marked\\:\\ 0\\.004555846312328561\ \(0\)\
\-\ unknown\\:\\ 0\\.004555846312328561\ \(0\)\
\-\ rate\\:\\ 0\\.004550165970595414\ \(0\)\
\-\ previous\\:\\ 0\\.004533265298734011\ \(0\)\
\-\ malignancy\\:\\ 0\\.004511051472406442\ \(0\)\
\-\ note\\:\\ 0\\.004505553999319386\ \(0\)\
\-\ used\\:\\ 0\\.004478393657032734\ \(0\)\
\-\ classic\\:\\ 0\\.00447302579072141\ \(0\)\
\-\ throughout\\:\\ 0\\.004369873396584599\ \(0\)\
\-\ reported\\:\\ 0\\.004255566735759306\ \(0\)\
\-\ vein\\:\\ 0\\.004223952625702346\ \(0\)\
\-\ male\\:\\ 0\\.0042218730543373585\ \(0\)\
\-\ including\\:\\ 0\\.004215052788241699\ \(0\)\
\-\ muscle\\:\\ 0\\.0041930535975769736\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.004184352165492985\ \(0\)\
\-\ status\\:\\ 0\\.004167113826750893\ \(0\)\
\-\ extension\\:\\ 0\\.004167113826750893\ \(0\)\
\-\ obtained\\:\\ 0\\.004150090301562626\ \(0\)\
\-\ palpable\\:\\ 0\\.004137460440710097\ \(0\)\
\-\ typically\\:\\ 0\\.004120800231565536\ \(0\)\
\-\ obstruction\\:\\ 0\\.004116666733045677\ \(0\)\
\-\ complete\\:\\ 0\\.00410843706828696\ \(0\)\
\-\ that\\:\\ 0\\.004032734231035036\ \(0\)\
\-\ long\\:\\ 0\\.004024892774361645\ \(0\)\
\-\ less\\:\\ 0\\.003953469951260495\ \(0\)\
\-\ type\\:\\ 0\\.003935279000473921\ \(0\)\
\-\ internal\\:\\ 0\\.003913764851610343\ \(0\)\
\-\ initial\\:\\ 0\\.003868281616501787\ \(0\)\
\-\ radiation\\:\\ 0\\.0038309443300031916\ \(0\)\
\-\ disease\\:\\ 0\\.003816222790206842\ \(0\)\
\-\ body\\:\\ 0\\.003791343869793831\ \(0\)\
\-\ several\\:\\ 0\\.0037528590651945185\ \(0\)\
\-\ such\\:\\ 0\\.0036493617347552625\ \(0\)\
\-\ during\\:\\ 0\\.003572417008092634\ \(0\)\
\-\ age\\:\\ 0\\.0035531561824375772\ \(0\)\
\-\ as\\:\\ 0\\.0035316325297653764\ \(0\)\
\-\ renal\\:\\ 0\\.003507480258822499\ \(0\)\
\-\ abdomen\\:\\ 0\\.0034581752225351045\ \(0\)\
\-\ demonstrated\\:\\ 0\\.0034254371345040537\ \(0\)\
\-\ pulmonary\\:\\ 0\\.00341058785549189\ \(0\)\
\-\ not\\:\\ 0\\.003373821507491627\ \(0\)\
\-\ cystic\\:\\ 0\\.003366984572748304\ \(0\)\
\-\ when\\:\\ 0\\.0033433486852677673\ \(0\)\
\-\ of\\:\\ 0\\.0033423221540406518\ \(0\)\
\-\ through\\:\\ 0\\.0033155150524875254\ \(0\)\
\-\ head\\:\\ 0\\.0033109307521501314\ \(0\)\
\-\ time\\:\\ 0\\.0032972694361192794\ \(0\)\
\-\ likely\\:\\ 0\\.003292745855103356\ \(0\)\
\-\ chronic\\:\\ 0\\.003288237203424863\ \(0\)\
\-\ ct\\:\\ 0\\.0032658569764809917\ \(0\)\
\-\ he\\:\\ 0\\.003257086532831994\ \(0\)\
\-\ and\\:\\ 0\\.003196881249342677\ \(0\)\
\-\ months\\:\\ 0\\.0031884443916530975\ \(0\)\
\-\ presented\\:\\ 0\\.0031821825615060235\ \(0\)\
\-\ been\\:\\ 0\\.003175949302546436\ \(0\)\
\-\ lobe\\:\\ 0\\.003141154846890074\ \(0\)\
\-\ up\\:\\ 0\\.003139135452259868\ \(0\)\
\-\ cm\\:\\ 0\\.0031310875926461555\ \(0\)\
\-\ lesions\\:\\ 0\\.0031250826589398193\ \(0\)\
\-\ evidence\\:\\ 0\\.0030607139117033847\ \(0\)\
\-\ common\\:\\ 0\\.0030550098523994497\ \(0\)\
\-\ who\\:\\ 0\\.0030436726900842925\ \(0\)\
\-\ anterior\\:\\ 0\\.0030065475734463625\ \(0\)\
\-\ prior\\:\\ 0\\.002997421819948584\ \(0\)\
\-\ both\\:\\ 0\\.0029811475282597285\ \(0\)\
\-\ more\\:\\ 0\\.002919639766819899\ \(0\)\
\-\ symptoms\\:\\ 0\\.002909368137838988\ \(0\)\
\-\ bone\\:\\ 0\\.0029008670511746857\ \(0\)\
\-\ consistent\\:\\ 0\\.002862429329004376\ \(0\)\
\-\ surgery\\:\\ 0\\.002834698175355567\ \(0\)\
\-\ noted\\:\\ 0\\.002766968836683871\ \(0\)\
\-\ or\\:\\ 0\\.002736400953452753\ \(0\)\
\-\ other\\:\\ 0\\.002690763044675476\ \(0\)\
\-\ posterior\\:\\ 0\\.002690763044675476\ \(0\)\
\-\ can\\:\\ 0\\.0026478447438102043\ \(0\)\
\-\ well\\:\\ 0\\.0026408209740008894\ \(0\)\
\-\ \\'s\\:\\ 0\\.002573834178097056\ \(0\)\
\-\ case\\:\\ 0\\.0025539678044634844\ \(0\)\
\-\ large\\:\\ 0\\.00255265359539765\ \(0\)\
\-\ but\\:\\ 0\\.0024897586079693137\ \(0\)\
\-\ right\\:\\ 0\\.0024634746150557834\ \(0\)\
\-\ multiple\\:\\ 0\\.002458751370873318\ \(0\)\
\-\ treatment\\:\\ 0\\.0023628646989083154\ \(0\)\
\-\ also\\:\\ 0\\.002301392887527529\ \(0\)\
\-\ by\\:\\ 0\\.0019438127093509218\ \(0\)\
\-\ at\\:\\ 0\\.0015816436514093347\ \(0\)\
\-\ \\.\\:\\ 0\\.0015518922884085802\ \(0\)\
\-\ was\\:\\ 0\\.0013501059046635065\ \(0\)\
\-\ left\\:\\ 0\\.0013061547394438726\ \(0\)\
\-\ with\\:\\ 0\\.0009590506236876208\ \(0\)\
